Position in MRNA
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$5,080
+$2,131 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VISION FINANCIAL MARKETS LLC holds $1,320,824 across 6 Biotechnology names. MRNA ranks #3 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLS |
SELLAS Life Sciences Group, Inc.
|
304,400 | $1,287,612 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
3,000 | $27,030 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
100 | $5,080 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
20 | $951 | |
| 5 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
14 | $131 | |
| 6 | MTNB |
Matinas BioPharma Holdings, Inc.
|
40 | $20 |
All Filings in MRNA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,080 | 100 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,949 | 100 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $2,583 | 100 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,759 | 100 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,835 | 100 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,158 | 100 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||